Search details
1.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38112922
2.
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
J Gynecol Oncol
; 32(5): e82, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34378365
Results
1 -
2
de 2
1
Next >
>>